13 Patents
- US125345332026Anti-chemokine Like Receptor 1 Humanized Antibodies and Their Therapeutic Applications
OSE IMMUNOTHERAPEUTICS
0 cites - US124484542025Humanized Anti-clec-1a Antibodies and Antigen-binding Fragments Thereof
OSE IMMUNOTHERAPEUTICS
0 cites - 0 cites
- 0 cites
- US123311182025Humanized Anti-human-pd-1 Antibody and Methods of Using Them for Cancer Treatment
OSE IMMUNOTHERAPEUTICS
0 cites - 0 cites
- US122585772025Method Effector Cells Using Anti-cd127 Antibodies for Applications in Cell Therapy
Assistance Publique—hopitaux De Paris
0 cites - 0 cites
- US120914642024Method of Promoting a T-cell Response or Treating Cancer by Administering an Antagonist to Human C-type Lectin-like Receptor-1 (CLEC-1)
OSE IMMUNOTHERAPEUTICS
0 cites - US120778202024Biomarkers for Assessing the Response Status for Treatment of Inflammatory Condition or Disease Affecting the Digestive Tract Such as Inflammatory Bowel Disease in Human Patients
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES
0 cites - 0 cites
- US118847232024Use of Anti-human Sirpa V1 Antibodies and Method for Producing Anti-sirpa V1 Antibodies
OSE IMMUNOTHERAPEUTICS
0 cites - US117133562023Modified Bifunctional Anti-human Signal Regulatory Protein Alpha (sirpa) Antibody and Method of Use Thereof for Treating Cancer
OSE IMMUNOTHERAPEUTICS
0 cites